Literature DB >> 33103626

Superior vena cava syndrome.

Peter Franz Klein-Weigel1, Saban Elitok2, Andreas Ruttloff1, Sabine Reinhold1, Jessika Nielitz1, Julia Steindl1, Birgit Hillner3, Lars Rehmenklau-Bremer3, Christian Wrase4, Heiko Fuchs4, Thomas Herold3, Lukas Beyer4.   

Abstract

The superior vena cava syndrome (SVCS) is caused by compression, invasion, and/or thrombosis of the superior vena cava and/or the brachiocephalic veins. Benign SVCS is separated from malignant SVCS. SVCS comprises a broad clinical spectrum reaching from asymptomatic cases to rare life-threatening emergencies with upper airway obstruction and increased intracranial pressure. Symptoms are correlated to the acuity and extent of the venous obstruction and inversely correlated to the development of the venous collateral circuits. Imaging is necessary to determine the exact underlying cause and to guide further interventions. Interventional therapy has widely changed the therapeutic approach in symptomatic patients. This article provides an overview over this complex syndrome and focuses on interventional therapeutic methods and results.

Entities:  

Keywords:  superior vena cava syndrome; superior vena cava thrombosis; thrombaspiration; thrombolysis; tumor compression; venous stenting

Mesh:

Year:  2020        PMID: 33103626     DOI: 10.1024/0301-1526/a000908

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  4 in total

1.  Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years' practice.

Authors:  Manuel Guhlich; Teresa Esther Maag; Leif Hendrik Dröge; Rami A El Shafie; Andrea Hille; Sandra Donath; Markus Anton Schirmer; Olga Knaus; Friedemann Nauck; Tobias Raphael Overbeck; Marc Hinterthaner; Wolfgang Körber; Stefan Andreas; Achim Rittmeyer; Martin Leu; Stefan Rieken
Journal:  Strahlenther Onkol       Date:  2022-05-12       Impact factor: 3.621

2.  Successful removal of a thrombus in the setting of SVC syndrome using the INARI FlowTriever device.

Authors:  John M Sousou; Douglass M Sherard; Jamie R Edwards; Elsio Negron-Rubio
Journal:  Radiol Case Rep       Date:  2021-12-28

Review 3.  Thrombosis associated with ventriculoatrial shunts.

Authors:  Dengjun Wu; Zhengyan Guan; Limin Xiao; Donghai Li
Journal:  Neurosurg Rev       Date:  2021-10-13       Impact factor: 3.042

4.  Impact of altered vena cava flow rates on right atrium flow characteristics.

Authors:  Louis P Parker; Anders Svensson Marcial; Torkel B Brismar; Lars Mikael Broman; Lisa Prahl Wittberg
Journal:  J Appl Physiol (1985)       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.